Product Name:4-chloro-7H-pyrrolo[2,3-d]pyrimidine

IUPAC Name:4-chloro-7H-pyrrolo[2,3-d]pyrimidine

CAS:3680-69-1
Molecular Formula:C6H4ClN3
Purity:95%+
Catalog Number:CM101908
Molecular Weight:153.57

Packing Unit Available Stock Price($) Quantity
CM101908-100g in stock Ɠľ
CM101908-500g in stock ƥľƿ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:3680-69-1
Molecular Formula:C6H4ClN3
Melting Point:-
Smiles Code:ClC1=C2C=CNC2=NC=N1
Density:
Catalog Number:CM101908
Molecular Weight:153.57
Boiling Point:325.9°C at 760 mmHg
MDL No:MFCD01686865
Storage:Keep in a dry and a tight container and store at ambient temperature

Category Infos

Pyrrolopyrimidines
Fusion heterocyclic compounds have various biological activities, such as anticancer, antibacterial, antifungal and anti-inflammatory, and thus have been widely used in the field of medicinal chemistry. Pyrrolopyrimidines are a major class of fused heterocyclic compounds. Compared with single pyrrole and pyrimidine cores, pyrrolopyrimidines have more diverse and effective pharmacological characteristics as fusion scaffolds.

Column Infos

Delgocitinib
Positive phase 3 head-to-head data results from DELTA FORCE trial comparing delgocitinib cream with alitretinoin capsules in adults with severe chronic hand eczema (CHE). Delgocitinib cream demonstrated a superior reduction in Hand Eczema Severity Index score from baseline to Week 12 compared to alitretinoin capsules as its primary outcome measure.
Delgocitinib cream is an investigational, first-in-class, topical pan-Janus kinase (JAK) inhibitor for CHE. It inhibits the activation of JAK-STAT signaling, which plays a key role in the pathogenesis of CHE.